71610-322 : Ranolazine 500 mg Oral Tablet, Film Coated, Extended Release


NDC: 71610-322
Labeler: Aphena Pharma Solutions - Tennessee, LLC
Product Type: Human Prescription Drug
Drug Name:  Ranolazine
Dosage Form: Oral Tablet, Film Coated, Extended Release
Application #: ANDA211829
Rev. Date: 


Appearance:


Markings: SG;423
Shapes:  Oval
Colors:  Orange
Size (mm): 17
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 71610-322-83: 3600 TABLET, FILM COATED, EXTENDED RELEASE IN 1 PACKAGE (71610‑322‑83)

Active Ingredients:

  • Ranolazine

Dosage Strength:

  • 500 mg

Inactive Ingredients:

  • Microcrystalline Cellulose
  • Methacrylic Acid - Ethyl Acrylate Copolymer (1:1) Type a
  • Sodium Lauryl Sulfate
  • Polysorbate 80
  • Hypromellose, Unspecified
  • Sodium Hydroxide
  • Magnesium Stearate
  • Hypromellose 2910 (15 Mpa.s)
  • Titanium Dioxide
  • Lactose Monohydrate
  • Polyethylene Glycol, Unspecified
  • Triacetin
  • Ferric Oxide Red
  • Ferric Oxide Yellow /

Pharmaceutical Classes:

  • Anti-anginal [EPC]
  • Cytochrome P450 3A Inhibitors [MoA]
  • P-Glycoprotein Inhibitors [MoA]
  • Cytochrome P450 2D6 Inhibitors [MoA]
  • Organic Cation Transporter 2 Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 71610-518 Ranolazine 500 mg Oral Tablet, Film Coated, Extended Release by Aphena Pharma Solutions - Tennessee, LLC
  • 27241-125 Ranolazine 500 mg Oral Tablet, Extended Release by Ajanta Pharma Limited
  • 27241-126 Ranolazine 1000 mg Oral Tablet, Extended Release by Ajanta Pharma Limited
  • 29300-296 Ranolazine 500 mg Oral Tablet, Film Coated, Extended Release by Unichem Pharmaceuticals (Usa), Inc.
  • 29300-297 Ranolazine 1000 mg Oral Tablet, Film Coated, Extended Release by Unichem Pharmaceuticals (Usa), Inc.
  • 31722-668 Ranolazine 500 mg Oral Tablet, Film Coated, Extended Release by Camber Pharmaceuticals, Inc.
  • 31722-669 Ranolazine 1000 mg Oral Tablet, Film Coated, Extended Release by Camber Pharmaceuticals, Inc.
  • 42291-773 Ranolazine 500 mg Oral Tablet, Film Coated, Extended Release by Avkare
  • 42291-774 Ranolazine 1000 mg Oral Tablet, Film Coated, Extended Release by Avkare
  • 42385-963 Ranolazine 500 mg Oral Tablet, Film Coated, Extended Release by Laurus Generics Inc.
  • 42385-964 Ranolazine 1000 mg Oral Tablet, Film Coated, Extended Release by Laurus Generics Inc.
  • 42571-324 Ranolazine 500 mg Oral Tablet, Extended Release by Micro Labs Limited
  • 42571-325 Ranolazine 1000 mg Oral Tablet, Extended Release by Micro Labs Limited
  • 43975-289 Ranolazine 1 g/1 Oral Tablet, Extended Release by Amerigen Pharmaceuticals Inc.
  • 43975-290 Ranolazine 500 mg Oral Tablet, Extended Release by Amerigen Pharmaceuticals Inc.
  • 45963-418 Ranolazine 500 mg Oral Tablet, Film Coated, Extended Release by Actavis Pharma, Inc.
  • 45963-419 Ranolazine 1000 mg Oral Tablet, Film Coated, Extended Release by Actavis Pharma, Inc.
  • 48792-7893 Ranolazine 500 mg Oral Tablet, Film Coated, Extended Release by Sunshine Lake Pharma Co., Ltd.
  • 48792-7894 Ranolazine 1000 mg Oral Tablet, Film Coated, Extended Release by Sunshine Lake Pharma Co., Ltd.
  • 50228-423 Ranolazine 500 mg Oral Tablet, Film Coated, Extended Release by Sciegen Pharmaceuticals, Inc
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 71610-322 QR Code

< Prev: 71610-321Next: 71610-323 >

Related Discussions:

Ranolazine 500mg
My mother is 65 years old, consuming Ranolazine - but i dont know what for? Please advise me. ## Ranolazine, the active ... 3 replies
can Nikoran be used with ranolazine
In refractory angina after angioplasty what should be treatment guidelines ## I'm using nicorandil 10mg twice daily ... 1 reply
Ranolazine for SOB
I am 82 now. When I walk some distance I get heavy breathing. Indoors I am perfectly ok. CT angiogram and ECG normal. No...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.